Literature DB >> 23167526

Garcinia xanthones as orally active antitumor agents.

Xiaojin Zhang1, Xiang Li, Haopeng Sun, Xiaojian Wang, Li Zhao, Yuan Gao, Xiaorong Liu, Shenglie Zhang, Yanyan Wang, Yingrui Yang, Su Zeng, Qinglong Guo, Qidong You.   

Abstract

Using a newly developed strategy whose key step is the regioselective propargylation of hydroxyxanthone substrates, 99 structurally diverse Garcinia natural-product-like xanthones based on gambogic acid were designed and synthesized and their in vitro antitumor activity was evaluated. A set of 40 related compounds was chosen for determination of their physicochemical properties including polar surface area, log D₇.₄, aqueous solubility, and permeability at pH 7.4. In the light of the in vitro antitumor activity and the physicochemical properties, two compounds were advanced into in vivo efficacy experiments. The antitumor activity of compound 112, administered po, showed more potent in vivo oral antitumor activity than gambogic acid.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23167526     DOI: 10.1021/jm301593r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

Review 1.  Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs.

Authors:  Meng Li; Fali Su; Mingtao Zhu; Huan Zhang; Yuxin Wei; Yang Zhao; Jianmin Li; Shaowa Lv
Journal:  Molecules       Date:  2022-05-04       Impact factor: 4.927

2.  Single-walled carbon nanotube and graphene nanodelivery of gambogic acid increases its cytotoxicity in breast and pancreatic cancer cells.

Authors:  Lamya M Saeed; Meena Mahmood; Sebastian J Pyrek; Tariq Fahmi; Yang Xu; Thikra Mustafa; Zeid A Nima; Stacie M Bratton; Dan Casciano; Enkeleda Dervishi; Anna Radominska-Pandya; Alexandru S Biris
Journal:  J Appl Toxicol       Date:  2014-09-12       Impact factor: 3.446

3.  Novel Natural Product-like Caged Xanthones Bearing a Carbamate Moiety Exhibit Antitumor Potency and Anti-Angiogenesis Activity In vivo.

Authors:  Xiaoli Xu; Yue Wu; Mingyang Hu; Xiang Li; Qichao Bao; Jinlei Bian; Qidong You; Xiaojin Zhang
Journal:  Sci Rep       Date:  2016-10-21       Impact factor: 4.379

4.  Beyond the Antagonism: Self-Labeled Xanthone Inhibitors as Modeled "Two-in-One" Drugs in Cancer Therapy.

Authors:  Fu-Chao Yu; Xin-Rong Lin; Zhi-Cheng Liu; Ji-Hong Zhang; Fei-Fei Liu; Wei Wu; Yu-Lu Ma; Wen-Wen Qu; Sheng-Jiao Yan; Jun Lin
Journal:  ACS Omega       Date:  2017-03-13

5.  Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells.

Authors:  Junqi Wu; Jinwei Dai; Yuyang Zhang; Jing Wang; Lei Huang; Hongmei Ding; Tiejun Li; Yuefan Zhang; Junqin Mao; Shichong Yu
Journal:  Drug Des Devel Ther       Date:  2019-12-13       Impact factor: 4.162

6.  Synthesis of 8',11'-dihydrospiro[cyclohexane-1,2'-oxepino[2,3-h] chromen]-4'(3'H)-ones with ring closing metathesis as a key step.

Authors:  Prathima K; Ashok D; Sarasija M; Prabhakar Sripadi; Madhu Vemula; Venkata S Komarraju; Biswajit Gorai; Shyam Prakash
Journal:  RSC Adv       Date:  2018-11-16       Impact factor: 4.036

Review 7.  Target identification of anticancer natural products using a chemical proteomics approach.

Authors:  Swadhapriya Bhukta; Pushparathinam Gopinath; Rambabu Dandela
Journal:  RSC Adv       Date:  2021-08-18       Impact factor: 4.036

8.  'Click Chemistry' Synthesis of Novel Natural Product-Like Caged Xanthones Bearing a 1,2,3-Triazole Moiety with Improved Druglike Properties as Orally Active Antitumor Agents.

Authors:  Xiang Li; Yue Wu; Yanyan Wang; Qidong You; Xiaojin Zhang
Journal:  Molecules       Date:  2017-10-27       Impact factor: 4.411

9.  Synthesis, Characterization and Anticancer Efficacy Evaluation of Benzoxanthone Compounds toward Gastric Cancer SGC-7901.

Authors:  Yuan Fu; Yunran Xu; Yunjun Liu; Yi Wang; Ju Chen; Xiuzhen Wang
Journal:  Molecules       Date:  2022-03-18       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.